Gilder Gagnon Howe & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$110M Sell
337,088
-8,487
-2% -$2.77M 1.17% 22
2025
Q1
$93.3M Sell
345,575
-19,888
-5% -$5.37M 1.22% 22
2024
Q4
$86M Sell
365,463
-18,530
-5% -$4.36M 0.93% 32
2024
Q3
$106M Sell
383,993
-14,623
-4% -$4.02M 1.26% 21
2024
Q2
$96.9M Sell
398,616
-6,557
-2% -$1.59M 1.21% 20
2024
Q1
$60.6M Sell
405,173
-181,872
-31% -$27.2M 0.76% 41
2023
Q4
$112M Sell
587,045
-7,934
-1% -$1.52M 1.54% 16
2023
Q3
$105M Sell
594,979
-3,717
-0.6% -$658K 1.6% 15
2023
Q2
$114M Sell
598,696
-22,512
-4% -$4.28M 1.56% 17
2023
Q1
$124M Sell
621,208
-28,409
-4% -$5.69M 2.06% 10
2022
Q4
$154M Sell
649,617
-14,366
-2% -$3.41M 2.88% 4
2022
Q3
$133M Sell
663,983
-90,592
-12% -$18.1M 2.32% 8
2022
Q2
$110M Sell
754,575
-36,649
-5% -$5.35M 1.96% 9
2022
Q1
$129M Sell
791,224
-48,344
-6% -$7.89M 1.19% 19
2021
Q4
$142M Sell
839,568
-84,116
-9% -$14.3M 0.81% 38
2021
Q3
$174M Sell
923,684
-2,042
-0.2% -$386K 0.9% 30
2021
Q2
$157M Sell
925,726
-3,917
-0.4% -$664K 0.77% 40
2021
Q1
$131M Buy
929,643
+45,513
+5% +$6.43M 0.71% 41
2020
Q4
$115M Sell
884,130
-6,286
-0.7% -$817K 0.57% 56
2020
Q3
$130M Buy
890,416
+6,648
+0.8% +$968K 0.8% 30
2020
Q2
$131M Sell
883,768
-35,409
-4% -$5.24M 1.02% 26
2020
Q1
$100M Sell
919,177
-17,302
-2% -$1.88M 1.2% 16
2019
Q4
$108M Sell
936,479
-17,626
-2% -$2.03M 1.12% 23
2019
Q3
$76.7M Sell
954,105
-23,714
-2% -$1.91M 0.88% 41
2019
Q2
$71M Sell
977,819
-9,951
-1% -$722K 0.72% 54
2019
Q1
$92.3M Buy
987,770
+33,174
+3% +$3.1M 0.99% 33
2018
Q4
$69.6M Sell
954,596
-134,299
-12% -$9.79M 0.99% 33
2018
Q3
$95.3M Sell
1,088,895
-5,821
-0.5% -$509K 0.97% 33
2018
Q2
$108M Sell
1,094,716
-115,706
-10% -$11.4M 1.16% 23
2018
Q1
$144M Sell
1,210,422
-6,945
-0.6% -$827K 1.79% 9
2017
Q4
$155M Buy
1,217,367
+96,812
+9% +$12.3M 2.08% 8
2017
Q3
$132M Sell
1,120,555
-64,825
-5% -$7.62M 1.85% 9
2017
Q2
$94.5M Sell
1,185,380
-20,669
-2% -$1.65M 1.4% 14
2017
Q1
$61.8M Sell
1,206,049
-24,745
-2% -$1.27M 1.04% 27
2016
Q4
$46.1M Sell
1,230,794
-130,862
-10% -$4.9M 0.91% 34
2016
Q3
$92.3M Sell
1,361,656
-32,291
-2% -$2.19M 1.59% 10
2016
Q2
$77.4M Sell
1,393,947
-20,684
-1% -$1.15M 1.54% 11
2016
Q1
$88.8M Sell
1,414,631
-62,736
-4% -$3.94M 1.74% 13
2015
Q4
$139M Sell
1,477,367
-16,480
-1% -$1.55M 2.24% 7
2015
Q3
$120M Sell
1,493,847
-12,391
-0.8% -$996K 1.9% 8
2015
Q2
$181M Sell
1,506,238
-242,129
-14% -$29M 2.37% 7
2015
Q1
$183M Sell
1,748,367
-201,902
-10% -$21.1M 2.54% 7
2014
Q4
$189M Sell
1,950,269
-37,293
-2% -$3.62M 2.81% 6
2014
Q3
$155M Sell
1,987,562
-8,308
-0.4% -$649K 2.26% 10
2014
Q2
$126M Buy
1,995,870
+80,272
+4% +$5.07M 1.67% 15
2014
Q1
$129M Buy
1,915,598
+16,446
+0.9% +$1.1M 1.75% 14
2013
Q4
$122M Sell
1,899,152
-21,926
-1% -$1.41M 1.74% 15
2013
Q3
$123M Buy
1,921,078
+244,650
+15% +$15.7M 1.92% 9
2013
Q2
$52M Buy
+1,676,428
New +$52M 0.98% 36